C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2004
12/29/2004	EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/29/2004	EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004	EP1185211B1 Bioengineered anterior cruciate ligament
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004	EP1071768B1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
12/29/2004	EP1064393B1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
12/29/2004	EP1062321B1 Uses for humane non-autologous mesenchymal stem cells
12/29/2004	EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials
12/29/2004	EP1012334A4 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
12/29/2004	EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
12/29/2004	EP0954527B1 Glycine transporter-transfected cells and uses thereof
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558949A Preparing somatic embryo by utilizing rabbit oocyte
12/29/2004	CN1558916A Compositions and methods for generating chimeric heteromultimers
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation
12/29/2004	CN1557948A Method for parameter control of the process for culturing serum-suspension free animal cell
12/29/2004	CN1557947A Method and device for perfusion and culture of hematopoietic cell
12/29/2004	CN1557946A Method for transplanting consubstantial cell nucleus
12/29/2004	CN1557939A Growth factor containing cell culture solution additive
12/29/2004	CN1557838A SARS coronavirus nucleocapsid protein monoclonal antibody, hybridoma for producing the same, detection agent containing the same and use thereof
12/29/2004	CN1557141A Saussurea medusa Maxim cell line for stable high yielding of snow lotus flavone and its uses
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CA2570464A1 Use of cardiotrophin to modulate stem cell proliferation
12/29/2004	CA2570407A1 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004	CA2529882A1 Cell line and uses thereof
12/29/2004	CA2529652A1 Leukocyte cell banks
12/29/2004	CA2529573A1 Porcine islets cultured with porcine sertoli cells for xenotransplantation
12/29/2004	CA2529501A1 Rate controlled release of a pharmaceutical agent in a biodegradable device
12/29/2004	CA2528002A1 Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
12/29/2004	CA2527626A1 Method of generating islet beta-cells from exocrine pancreatic cells
12/29/2004	CA2526647A1 Anti alpha - folate - receptor - tetramer antibodies
12/29/2004	CA2525847A1 Tissue modeling in embryonic stem (es) cell system
12/29/2004	CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/28/2004	US6835875 For higher seed yield, resistance to diseases and insects, tolerance to drought/heat, and better agronomic qualities
12/28/2004	US6835867 For genetic mapping; in vitro stem cell cultures
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835816 Mammalian tumor susceptibility genes and their uses
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835569 Amino polyol oxidase amine polynucleotides and related polypeptides and methods of use
12/28/2004	US6835568 Regulated nucleic acid expression system
12/28/2004	US6835567 PNS cell lines and methods of use therefor
12/28/2004	US6835566 Culturing lineage committed human cells under liquid culture conditions, including replacement of liquid culture medium at a rate and for a time sufficient to obtain human lineage committed cells; skin, bone marrow replacements, therapy
12/28/2004	US6835561 Composition of reverse transcriptases and mutants thereof
12/28/2004	US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/28/2004	US6835548 Isoforms of mouse serotonin 5-HT2c receptor
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835538 Method of genetic modification of a wild type viral sequence
12/28/2004	US6835390 Method for producing tissue engineered meat for consumption
12/28/2004	US6835377 Regenerating articular cartilage defects by administering cultured human mesenchymal stem cells
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA1341469C In vitro propagation of embryonic stem cells
12/23/2004	WO2004111648A2 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules
12/23/2004	WO2004111610A2 Method and system for the analysis of high density cells samples
12/23/2004	WO2004111239A1 Human embryonic kidney (hek) 293 subclone cell strain
12/23/2004	WO2004111213A1 Process for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal neurocyte produced by the process
12/23/2004	WO2004111212A1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process
12/23/2004	WO2004111211A1 Differentiated cells originating in precursor fat cells and method of acquiring the same
12/23/2004	WO2004111210A1 Enhancement of oligodendrocyte differentiation
12/23/2004	WO2004111209A1 Monitoring method using micromembrane probes
12/23/2004	WO2004111208A1 Cartilage-derived stem cells and applications thereof
12/23/2004	WO2004111207A1 Multicellular in vitro model of angiogenesis and methods for using the same
12/23/2004	WO2004111206A1 A method for isolation and culture of human embtyonic stem cell
12/23/2004	WO2004111195A2 Methods and use of zona-free therapeutic cloning
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004110512A2 A method for cell implantation
12/23/2004	WO2004110372A2 Room temperature storage of organs
12/23/2004	WO2004110340A2 Ctla-2 and uses thereof
12/23/2004	WO2004099403A8 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
12/23/2004	WO2004097039A9 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
12/23/2004	WO2004092354A3 Ex vivo skin organ model, especially for human skin
12/23/2004	WO2004090091A3 Body with a culture surface for in-vitro propagation of cells
12/23/2004	WO2004076620A3 Human antibodies specific for interleukin 15 (il-15)
12/23/2004	WO2004074439A9 An expression cassette and vector for transient or stable expression of exogenous molecules
12/23/2004	WO2004063356A3 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
12/23/2004	WO2004062554A3 Enhancement of dopaminergic neuron generation and survital
12/23/2004	WO2004046312A3 Methods for in vitro expansion of hematopoietic stem cells
12/23/2004	WO2004031266A3 Cell adhesion resisting surfaces
12/23/2004	WO2004016747A3 Bone marrow cell differentiation
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003101497A8 Knockout mice and their use
12/23/2004	WO2003097805A3 Delivery of nucleic acid-like compounds
12/23/2004	WO2003077852A8 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	US20040261146 Genes coding for flavone synthases
12/23/2004	US20040261139 Androgen receptor knock-out transgenic animals
12/23/2004	US20040260079 Cardiac-cell specific enhancer elements and uses thereof
12/23/2004	US20040260067 Chimpanzee monoclonal antibodies and antigen binding fragments including complementary determining regions; drug screening; host cells; kits
12/23/2004	US20040260061 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity
12/23/2004	US20040259831 Methods and compositions for the introduction of molecules into cells
12/23/2004	US20040259830 converting a peptide solution to aerosol droplets which are produced by a microflow nebulizer at a flow rate of 1-100 mu l/minute and impacting a bacterial cell with accelerated aerosol droplets; preferably placing the cell on a target surface with separately controlled linear and rotational movement
12/23/2004	US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents

1 ... 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 ... 1827